These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15549413)

  • 41. Cardiovascular complications in pediatric end-stage renal disease.
    Parekh RS; Gidding SS
    Pediatr Nephrol; 2005 Feb; 20(2):125-31. PubMed ID: 15599775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular disease in dialysis patients.
    Cozzolino M; Mangano M; Stucchi A; Ciceri P; Conte F; Galassi A
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii28-iii34. PubMed ID: 30281132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical significance of vascular calcification in young patients with end-stage renal disease.
    Querfeld U
    Pediatr Nephrol; 2004 May; 19(5):478-84. PubMed ID: 15015069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arterial stiffness and pulse pressure in CKD and ESRD.
    Briet M; Boutouyrie P; Laurent S; London GM
    Kidney Int; 2012 Aug; 82(4):388-400. PubMed ID: 22534962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular disease and mortality in ESRD.
    Foley RN; Parfrey PS
    J Nephrol; 1998; 11(5):239-45. PubMed ID: 9831236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension and future cardiovascular health in pediatric end-stage renal disease patients.
    Flynn JT
    Blood Purif; 2012; 33(1-3):138-43. PubMed ID: 22269342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
    Kielstein JT; Zoccali C
    Am J Kidney Dis; 2005 Aug; 46(2):186-202. PubMed ID: 16112037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cardiovascular burden of end-stage renal disease patients.
    Cianciolo G; Donati G; La Manna G; Ferri A; Cuna V; Ubaldi G; Corsini S; Lanci N; Colì L; Stefoni S
    Minerva Urol Nefrol; 2010 Mar; 62(1):51-66. PubMed ID: 20424570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
    Gusbeth-Tatomir P; Covic A
    Kidney Blood Press Res; 2007; 30(2):97-107. PubMed ID: 17374960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of hyperphosphataemia in the cardio-renal axis.
    Goodman WG
    Nephrol Dial Transplant; 2004 Mar; 19 Suppl 1():i4-8. PubMed ID: 15126647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcomes of children with end-stage renal disease.
    Groothoff JW
    Pediatr Nephrol; 2005 Jul; 20(7):849-53. PubMed ID: 15834618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal disease as a risk factor for cardiovascular disease.
    Luft FC
    Basic Res Cardiol; 2000; 95 Suppl 1():I72-6. PubMed ID: 11192357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients.
    Raggi P
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S62-5. PubMed ID: 11158864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cardiovascular diseases in patients with chronic renal diseases].
    Dimković N
    Srp Arh Celok Lek; 2008 May; 136 Suppl 2():135-41. PubMed ID: 18924484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arterial structure and function in end-stage renal disease.
    Guérin AP; Pannier B; Marchais SJ; London GM
    Curr Hypertens Rep; 2008 Apr; 10(2):107-11. PubMed ID: 18474176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular risk factors in chronic renal failure and hemodialysis populations.
    Ma KW; Greene EL; Raij L
    Am J Kidney Dis; 1992 Jun; 19(6):505-13. PubMed ID: 1534442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach.
    London GM; Marchais SJ; Guérin AP; Métivier F
    Nephrol Dial Transplant; 2002; 17 Suppl 11():13-5. PubMed ID: 12386250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage renal disease.
    Raggi P
    Nephrol Dial Transplant; 2002 Feb; 17(2):332-5. PubMed ID: 11812901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal disease and the heart.
    Woolfson RG
    Hosp Med; 1999 Feb; 60(2):85-9. PubMed ID: 10320836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.